A mobile application used to assess sports-related head and brain injuries is now being tested for detecting and monitoring neurological disorders.
BrainEye's mobile test is now being studied in clinical trials at The Alfred Hospital in Melbourne. It digitises the traditional eye movement test, which is done in 60 seconds through a mobile device, and then collects and measures over 20 ocular...
Belfast-based health tech company, Neurovalens, has raised £5.1 million in funding led by IQ Capital.
Wharton Asset Management Company, The Angel CoFund (ACF), Techstart Ventures, Clarendon Fund Managers, and the Government’s Future Fund also contributed to the funding round.
The funding will be used for clinical trial research and development in the UK and abroad, as well as hiring additional...
